198 related articles for article (PubMed ID: 1306297)
1. Mass screening for neuroblastoma in Miyagi Prefecture.
Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
[TBL] [Abstract][Full Text] [Related]
2. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
Sato Y; Hanai J; Takasugi N; Takeda T
Tohoku J Exp Med; 1986 Oct; 150(2):169-74. PubMed ID: 3810642
[TBL] [Abstract][Full Text] [Related]
3. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
Sawada T
Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
[No Abstract] [Full Text] [Related]
4. Screening for neuroblastoma in North America. 2-year results from the Quebec Project.
Woods WG; Tuchman M; Bernstein ML; Leclerc JM; Brisson L; Look T; Brodeur GM; Shimada H; Hann HL; Robison LL
Am J Pediatr Hematol Oncol; 1992 Nov; 14(4):312-9. PubMed ID: 1456396
[TBL] [Abstract][Full Text] [Related]
5. Mass screening for neuroblastoma in infants.
Wei M; Ye M; Dong K; Dong R
Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
[TBL] [Abstract][Full Text] [Related]
6. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
Yokomori K; Hori T; Tsuchida Y; Kuroda M; Yoshioka M
J Pediatr Surg; 1989 Apr; 24(4):391-4. PubMed ID: 2659761
[TBL] [Abstract][Full Text] [Related]
7. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Hanai J; Kawai T
Jpn J Clin Oncol; 1990 Sep; 20(3):268-70. PubMed ID: 2255102
[TBL] [Abstract][Full Text] [Related]
8. Results of mass screening for neuroblastoma in Sapporo, Japan.
Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
[No Abstract] [Full Text] [Related]
9. A simple coloured-paper thin-layer chromatography test as a backup procedure for vanillylmandelic acid and homovanillic acid evaluation in a neuroblastoma screening program.
Mathieu P; Philip T; Greffe J; Montegue A; Lacroix C
Clin Chim Acta; 1993 Nov; 220(2):229-32. PubMed ID: 8111967
[No Abstract] [Full Text] [Related]
10. Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Hashimoto T; Koizumi K; Nishina T; Abe K
Ann Nucl Med; 2003 Dec; 17(8):633-40. PubMed ID: 14971604
[TBL] [Abstract][Full Text] [Related]
11. Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
Hanai J; Kawai T; Sato Y; Takasugi N; Nishi M; Takeda T
Clin Chem; 1987 Nov; 33(11):2043-6. PubMed ID: 3677377
[TBL] [Abstract][Full Text] [Related]
12. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
[TBL] [Abstract][Full Text] [Related]
13. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
14. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
[TBL] [Abstract][Full Text] [Related]
15. Determination of homovanillic acid and vanillylmandelic acid in neuroblastoma screening by stable isotope dilution GC-MS.
Fauler G; Leis HJ; Huber E; Schellauf C; Kerbl R; Urban C; Gleispach H
J Mass Spectrom; 1997 May; 32(5):507-14. PubMed ID: 9180052
[TBL] [Abstract][Full Text] [Related]
16. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
[TBL] [Abstract][Full Text] [Related]
17. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yamashiro K; Takasugi N; Hanai J; Kawai T
Eur J Pediatr; 1990 Sep; 149(12):859-61. PubMed ID: 2226572
[TBL] [Abstract][Full Text] [Related]
18. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1986 Dec; 16(4):351-5. PubMed ID: 3795531
[TBL] [Abstract][Full Text] [Related]
19. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
20. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
